Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1532-1535 , December 1995

NG-Methyl-l-arginine and somatostatin decrease glucose and insulin and block endothelin-1 (ET-1)-induced insulin release but not ET-1-induced hypoglycemia

  • Robert S. Zimmerman

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Robert S. Zimmerman, MD, Endocrinology Research, Oshsner Clinic, 1516 Jefferson Highway, New Orleans, LA 70121.
    • ,
  • Michael Maymind

Received 21 July 1994 ,Accepted 22 May 1995.

References 

  1. Yanagisawa M, Kurihara H, Kimura S, et al.  A novel and potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–415
  2. Inoue A, Yanagisawa M, Kimura S, et al.  The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. In: ed 3. Proc Natl Acad Sci USA. 86:1989;p. 2863–2867
  3. Zimmerman RS, Martinez AJ, MacPhee AA, et al.  Cardiorenal effects of endothelin-3 in the rat. Life Sci. 1990;47:2323–2332
  4. Miller WL, Redfield MM, Burnett JC. Integrated cardiac, renal and endocrine actions of endothelin. J Clin Invest. 1989;83:317–320
  5. Goetz KL, Wang BC, Madwed JB, et al.  Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol. 1988;255:R1064–R1068
  6. Ohnishi A, Yamaguchi K, Kusuhara M, et al.  Mobilization of intracellular calcium by endothelin in Swiss 3T3 cells. Biochem Biophys Res Commun. 1989;161:489–495
  7. Resink TJ, Scott-Burden Y, B:uhler FR. Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1988;157:1360–1362
  8. Huang Y-T, Hamilton CA, Reid JL. Endothelin stimulates phosphatidylinositol hydrolysis in rat vascular smooth muscles. J Hypertens. 1989;7:703–705
  9. Van Renterghem C, Vigne P, Barhanin J, et al.  Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun. 1988;157:977–985
  10. Cozza EN, Gomez-Sanchez CE, Foecking FM, et al.  Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest. 1989;84:1032–1035
  11. Hinson JP, Vinson GP, Kapas S, et al.  The role of endothelin in the control of adrenocortical function: Stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells. J Endocrinol. 1991;128:275–280
  12. Stojilkovic SS, Balla T, Fukud S, et al.  Endothelin ET, receptors mediate the signaling and secretory actions of endothelins in pituitary gonadotrophs. Endocrinology. 1992;130:465–474
  13. Zimmerman RS, Maymind M. Endothelin-1 decreases glucose, inhibits glucagon and stimulates insulin release in the rat. Metabolism (in press)
  14. Hegazy H, Brown DM, Kelley RE, et al.  Plasma endothelin-1 is increased independent of renal sources during the vasodilatot state induced by long term diabetes mellitus in the rat. Clin Res. 1993;41:666A; (abstr)
  15. Takahashi K, Ghatei MA, Lam HC, et al.  Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 1990;33:306–310
  16. Hegazy H, Osei K, Boudoulas H, et al.  Plasma endothelin is increased in patients with insulin dependent diabetes mellitus. Clin Res. 1993;4:667A; (abstr)
  17. Hu H-M, Frank HJL, Levin ER, et al.  Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocr Soc. 1993;492:1765; (abstr)
  18. Wanner TD, Mitchell JA, Denucci G, et al.  Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol. 1989;13:S85–S88
  19. Denucci G, Thomas R, D'Orleans-Juste P, et al.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. In: ed 3. Proc Natl Acad Sci USA. 85:1988;p. 9797–9800
  20. Fukuda N, Izumi Y, Soma M, et al.  l-NG monomethyl arginine inhibits the vasodilating effects of low dose of endothelin-3 on rat mesenteric arteries. Biochem Biophys Res Commun. 1990;167:739–745
  21. Harald HH, Schmidt W, Warner DTD, et al.  Insulin secretion from pancreatic B cells caused by l-arginine-derived nitrogen oxides. Science. 1992;255:721–723
  22. Jansson L, Sandler S. The nitric oxide synthase II inhibitor NG-nitro-l-arginine stimulates pancreatic islet insulin release in vitro, but not in the perfused pancreas. Endocrinology. 1991;128:3081–3085
  23. Brown M, Rivier J, Vale W. Biological activity of somatostatin and somatostatin analogs on inhibition of arginine-induced insulin and glucagon release in the rat. Endocrinology. 1976;98:336–343
  24. Johnson DG, Ensinck JW, Koerker D, et al.  Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ. Endocrinology. 1975;96:370
  25. Reichlin S. Somatostatin. I. N Engl J Med. 1983;309:1495–1501
  26. Reichlin S. Somatostatin. II. N Engl J Med. 1983;309:1556–1563
  27. Szecowka J, Lins PE, Efendic S. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats. Endocrinology. 1982;110:1268–1272

☆ Presented in part at the American Federation for Clinical Research, Baltimore, MD, April 30, 1994; Annual Meeting of the Midwest AFCR, Chicago, IL, November 4, 1992; and the American Diabetes Association, Las Vegas, NE, June 15, 1993.

☆☆ Supported by a grant from the Ochsner Medical Foundation.

PII: 0026-0495(95)90070-5

Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1532-1535 , December 1995

Article Tools